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surgical intervention should be performed only in selected
cases, such as those with persistent organ complications or
severe clinical deterioration despite maximum intensive care;
(4) early surgical intervention is not recommended for necro-
tizing pancreatitis; (5) necrosectomy is recommended as the
surgical procedure for infected pancreatic necrosis; (6) simple
drainage should be avoided after necrosectomy, and either
continuous closed lavage or open drainage should be per-
formed; (7) surgical or percutaneous drainage should be per-
formed for pancreatic abscess; (8) pancreatic abscesses for
which clinical ﬁndings are not improved by percutaneous
drainage should be subjected to surgical drainage immedi-
ately; (9) pancreatic pseudocysts that produce symptoms and
complications or the diameter of which increases should be
drained percutaneously or endoscopically; and (10) pancreatic
pseudocysts that do not tend to improve in response to percu-
taneous drainage or endoscopic drainage should be managed
surgically.
Key words  Necrotizing pancreatitis · Infected pancreatic
necrosis · Sterile pancreatic necrosis · Pancreatic abscess ·
Pancreatic pseudocyst
Clinical questions
CQ1. Which procedure will best result in a deﬁnite
diagnosis of infected pancreatic necrosis?
CQ2. What is the indication for surgical interven-
tion in necrotizing pancreatitis?
CQ3. How should sterile pancreatic necrosis be
managed?
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Abstract
Acute pancreatitis represents a spectrum of disease ranging
from a mild, self-limited course to a rapidly progressive, se-
vere illness. The mortality rate of severe acute pancreatitis
exceeds 20%, and some patients diagnosed as mild to moder-
ate acute pancreatitis at the onset of the disease may progress
to a severe, life-threatening illness within 2–3 days. The
Japanese (JPN) guidelines were designed to provide recom-
mendations regarding the management of acute pancreatitis
in patients having a diversity of clinical characteristics. This
article sets forth the JPN guidelines for the surgical manage-
ment of acute pancreatitis, excluding gallstone pancreatitis, by
incorporating the latest evidence for the surgical management
of severe pancreatitis in the Japanese-language version of the
evidence-based Guidelines for the Management of Acute Pan-
creatitis published in 2003. Ten guidelines are proposed: (1)
computed tomography-guided or ultrasound-guided ﬁne-
needle aspiration for bacteriology should be performed in
patients suspected of having infected pancreatic necrosis; (2)
infected pancreatic necrosis accompanied by signs of sepsis is
an indication for surgical intervention; (3) patients with sterile
pancreatic necrosis should be managed conservatively, andS. Isaji et al.: Surgical management of acute pancreatitis 49
CQ4. What is the optimal timing for surgical
intervention?
CQ5. What is the optimal surgical procedure for
infected pancreatic necrosis?
CQ6. What is the optimal drainage procedure after
necrosectomy?
CQ7. How should pancreatic abscess be managed?
CQ8. What is the indication for surgical drainage in
pancreatic abscess?
CQ9. What are the indications for drainage treat-
ment in pancreatic pseudocysts?
CQ10. What is the indication for surgical interven-
tion in pancreatic pseudocysts?
Introduction
Research on the pathophysiology of acute pancreatitis
has progressed dramatically during the past 20 years. As
the number of randomized controlled studies (RCTs,
mainly done in the United States and Europe) on
the management of severe acute pancreatitis has in-
creased, evidence-based management has come to be
demanded. Several guidelines and recommendations
for acute pancreatitis have been published in recent
years,1–4 and three institutions in Japan — the Japanese
Society for Abdominal Emergency Medicine, the Japan
Pancreas Society, and the Research Group for Intrac-
table Diseases and Refractory Pancreatic Diseases,
which is sponsored by the Japanese Ministry of Health,
Labour and Welfare — collaborated to publish the
Japanese-language version of the evidence-based
Guidelines for the Management of Acute Pancreatitis in
2003. This paper sets forth the JPN guidelines for the
surgical management of acute pancreatitis, which incor-
porate the latest evidence for the surgical management
of severe pancreatitis and are based on the Japanese-
language version of the guidelines. The surgical man-
agement of gallstone pancreatitis is included in the JPN
guidelines for the treatment of gallstone-associated
acute pancreatitis.
Clinical course of acute pancreatitis
The majority of acute pancreatitis cases (around 80%)
are mild and self-limiting, and the patients spontane-
ously recover within 4–5 days after onset. Mild cases
have a mortality rate of 1% or less and rarely require
intensive care or surgical management.1
However, severe acute pancreatitis develops in 10%–
20% of cases and part of the pancreas and surrounding
tissue becomes necrotic. Severe cases are associated
with local complications such as major organ failure,
pancreatic necrosis, pancreatic abscess, and pancreatic
pseudocysts and are generally classiﬁed into two stages.5
The ﬁrst stage of severe acute pancreatitis, the period
within 2 weeks after the onset of the disease, is charac-
terized by the systemic inﬂammatory response syn-
drome (SIRS), and pancreatic necrosis develops in
parallel with that within the ﬁrst 4 days after onset. The
second stage begins 2 or 3 weeks after onset with the
development of infectious pancreatic complications
such as infected pancreatic necrosis (bacterial infection
of the pancreatic necrosis) and pancreatic abscess. In-
fection of pancreatic necrosis is a major prognostic risk
factor in severe pancreatitis, and sepsis-related multiple
organ failure is the main life-threatening complication
with a mortality rate of 20%–50%.
Necrotizing pancreatitis
Clinical Question (CQ) 1. Which procedure will best
result in a deﬁnite diagnosis of infected pancreatic
necrosis?
Computed tomography (CT)-guided or ultrasound
(US)-guided ﬁne-needle aspiration for bacteriology
should be performed in patients suspected of
having infected pancreatic necrosis (Recommendation
A)
Acute pancreatitis is classiﬁed morphologically into
edematous pancreatitis and necrotizing pancreatitis.
Edematous pancreatitis accounts for 80%–85% of cases
of acute pancreatitis, and most of them are self-limiting
and do not require special treatment. The mortality rate
for necrotizing pancreatitis, which accounts for 15%–
20% of cases, is 30%–40%.6 The mortality rate for in-
fected pancreatic necrosis is high — 40% on average,7
and some studies report rates of more than 70%.8 In
contrast, the mortality rate of sterile pancreatic necrosis
with no bacterial infection has been reported as being
0%–11%.9,10
Findings suggest that infected pancreatic necrosis
presents with a worsening of clinical manifestations and
hematological data, a blood culture with positive bacte-
rial results, and a positive result on the endotoxin test of
blood and gas in and around the pancreas on a CT scan.
However, these ﬁndings are merely indirect evidence
of infection in general. CT- or US-guided ﬁne-needle
aspiration for bacteriology of pancreatic or peripan-
creatic necrosis has been established as an accurate,
safe, and reliable technique for identifying infected
necrosis. Its accuracy is high, at 89.4%–100% (Level
2b),11,12 and it is safe if the correct puncture route is
chosen and complications such as intestinal injury do
not result (Level 2b).50 S. Isaji et al.: Surgical management of acute pancreatitis
Indications for surgery
CQ2. What is the indication for surgical intervention
in necrotizing pancreatitis?
Infected pancreatic necrosis accompanied by signs
of sepsis is an indication for surgical intervention
(Recommendation B)
It is generally agreed that necrotizing pancreatitis with
proven infected necrosis is an indication for surgical
intervention (Level 5).1,13,14 It is rarely managed conser-
vatively without surgical intervention.
CQ3. How should sterile pancreatic necrosis be
managed?
Patients with sterile pancreatic necrosis should be
managed conservatively and undergo surgical inter-
vention only in selected cases, such as those with
persistent organ complications or severe clinical
deterioration despite maximum intensive care
(Recommendation B)
Whether sterile pancreatic necrosis is an indication for
surgical intervention remains a matter of controversy.
Patients often recover from sterile pancreatic necrosis
in response to conservative nonsurgical management
(Levels 2c–3b).9,15–17 However, many reports state that
failure of acute pancreatitis to improve in response to
optimal therapy in an intensive care unit should be an
indication for surgical intervention, irrespective of
whether the patient has an infection (Levels 2c–3b).18–22
However, these reports have differing views about the
length of time that conservative management should be
applied before surgical intervention is considered, with
the period ranging from 3–5 days to more than 5 weeks.
A review23 examining this issue has indicated that al-
though it is difﬁcult to recommend an exact duration, at
least 3–4 weeks of conservative management is desir-
able. However, there are no comparative studies to jus-
tify such a conclusion.
Timing of surgery
CQ4. What is the optimal timing for surgical
intervention?
Unless there are speciﬁc indications, early surgery is
not recommended for necrotizing pancreatitis
(Recommendation D)
In the past, early surgical intervention was recom-
mended for severe acute pancreatitis, which is often
accompanied by major organ failure, beginning in the
early stage after onset. However, the high mortality rate
of up to 65% casts doubt on the beneﬁts of early surgical
intervention.
A retrospective study on the timing of surgery for
severe pancreatitis24 revealed a mortality rate in patients
treated by delayed surgery of 12%, which is signiﬁcantly
lower than the 39% rate for those who underwent early
surgery; thus, surgical intervention should be delayed as
long as possible in severe pancreatitis. The only RCT25
comparing early surgery (pancreatic resection/debride-
ment within 72 h of onset) and delayed surgery (the
same procedure 11 days after onset) yielded mortality
rates of 56% and 27%, respectively. Although the dif-
ference between the rates was signiﬁcant, the trial was
terminated because of the very high mortality rate for
the patients who underwent early surgery.
The above ﬁndings indicate that surgical intervention
(necrosectomy) for severe acute pancreatitis patients
should be deferred as long as possible (3–4 weeks after
the onset).1,3 The reason for this is that the border be-
tween normal and necrotic pancreatic tissue becomes
more distinct with time, and this may minimize intra-
operative hemorrhage and avoid unnecessary removal
of normal pancreas. However, a questionnaire survey of
physicians specializing in hepatobiliary pancreatic dis-
eases in Europe that asked about surgical intervention
for severe pancreatitis showed no consensus regarding
the timing of surgery.26
Surgical procedures
CQ5. What is the optimal surgical procedure for in-
fected pancreatic necrosis?
Necrosectomy is recommended as the optimal surgical
procedure for infected pancreatic necrosis (Recommen-
dation A)
Surgical procedures employed to treat severe acute pan-
creatitis in the past included mobilization and drainage
of the pancreatic bed and extended pancreatic resection.
Drainage of the pancreatic bed was widely used in Japan
as a standard surgical procedure in the 1980s through the
early 1990s. However, it is no longer used because maxi-
mal therapy in an intensive care unit has become the
principal procedure for managing severe acute pancre-
atitis and the advances in imaging modalities have pro-
vided objective evidence that the necrotic tissue cannot
be removed by a simple drainage procedure.
On the other hand, the extended pancreatic resection
that was the major procedure used mainly in European
countries from the 1970s through the 1980s has been
increasingly avoided in view of the high incidence of
postoperative complications, the failure to improve the
overall life-saving rate (Level 1b–3b),27,28 and the low-
ered quality of life in surviving patients because of the
development of abnormal glucose tolerance.27
Necrosectomy, or debridement of necrotic tissue, in-
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necrosis, is currently used as the key procedure for
necrotizing pancreatitis, and no other surgical proce-
dure produces a better outcome (Level 2c).21,29
Drainage procedures after necrosectomy
CQ6. What is the optimal drainage procedure after
necrosectomy?
Simple drainage (Recommendation D)  should be
avoided as the drainage procedure after necrosectomy,
and either continuous closed lavage or open drainage
(planned necrosectomy) (Recommendation B) should
be performed instead. The choice between these two
procedures can be made at the time based on the surgi-
cal ﬁndings and/or surgeon’s experience
Necrosectomy for necrotizing pancreatitis is designed to
remove as much necrotic pancreatic tissue as possible.
However, because complete debridement is difﬁcult as
a result of hemorrhage and because the outcome de-
pends on how thoroughly the remaining necrotic tissue
is removed,29 the simple (conventional) drainage per-
formed in the past should be avoided.
The drainage procedures used to remove the necrotic
foci after necrosectomy can be mainly classiﬁed as (1)
conventional drainage, (2) continuous closed lavage,
and (3) open drainage. Conventional drainage is simple
drainage through an indwelling drainage tube. Continu-
ous closed lavage consists of continuous local irrigation
with 6–8l/day physiological saline through an indwelling
double-lumen tube and is continued until no discharge
of necrotic tissue is observed.21 Open drainage is direct
drainage through the open wound in the abdominal wall
achieved by packing the retroperitoneal space and
lesser sac with gauze after necrosectomy, and the same
procedure is repeated as scheduled (every 2–3 days)
until necrotic tissue is no longer observed.29
Discussion of the comparative advantages of various
drainage procedures has continued for more than 20
years, and two reviews based on systematic literature
searches have been published. The ﬁrst review (Level
2a),30 published in 1991, analyzed relevant articles pub-
lished during the 1980s and revealed that the mortality
rate of patients with infected pancreatic necrosis treated
by conventional drainage, continuous closed lavage,
and open drainage was 42%, 18%, and 21%, respec-
tively, and that the outcome of the conventional drain-
age group was signiﬁcantly poorer (P < 0.05). The other
review (Level 2a),31 which analyzed articles published in
the 1990s, revealed that the mortality rate of the pa-
tients with infected pancreatic necrosis treated using the
above methods was 23.3%, 10.5%, and 28.3%, respec-
tively. When the analysis was limited to articles dealing
with severe cases [an average APACHE II (AP-II)
score of 17 or more], the mortality rate was 45.8%,
Table 1.
Systematic review of the outcomes of three major drainage procedures after necrosectomy for infected pancreatic necrosis
31
Necrosectomy with conventional drainage
Necrosectomy with continuous closed lavage
Necrosectomy with open drainage
Reference
n
AP-II
Deaths
Reference
n
AP-II
Deaths
Reference
n
AP-II
Deaths
Fernandez-del
36
10.6
3 (8.3%)
Farkas et al.
34
142
18.5
9 (6.3%)
Kriwanek et al.
37
63
11
16 (25.4%)
Castillo et al.
20
Branum et al.
35
42
—
3 (7.0%)
Bradley
38
46
14.6
6 (13.0%)
Harris et al.
32
91
84
 
(44.4%)
Chaudhary et al.
36
83
—
16 (19.3%)
Van Goor et al.
39
10
19
3 (30.0%)
Doglietto et al.
33
15
18
7 (46.7%)
Margulies and
10
—
3 (30.0%)
Akin
40
Harris et al. 32
11
18
2 (18.2%)
Doglietto et al.
33
13
17
3 (23.1%)
Orlando et al.
41
15
—
3 (20.0%)
Fugger et al.
42
87
—
34 (39.1%)
Schein
43
91
25
 
(55.6%)
Stanten and Frey
44
12
—
3 (25.0%)
Total
60
14 (23.3%)
Total
267
28 (10.5%)
Total
276
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6.3%, and 23.5%, respectively (Table 1). Both reviews
show that patients treated by continuous closed lavage
had the best outcome.
However, because of extreme inconsistency between
the results of two papers34,45 on continuous closed lav-
age, both of which were included in the latter systematic
review and were reported by the same author at almost
the same time, the reliability of the data is highly ques-
tionable. In another paper on continuous closed lav-
age,35  approximately half of the patients underwent
repeat laparotomy/debridement 12 or 13 times, and thus
the results reported in that paper cannot be considered
a pure reﬂection of the effect of continuous closed
lavage.
There is a planned necrosectomy/debridement proce-
dure in which necrosectomy is repeated by temporarily
closing the abdominal wound to avoid the excessive
invasiveness of open drainage (Level 2c).46  A recent
review compared continuous closed lavage, planned
necrosectomy (zipper technique), and open drainage.47
The report stated that the mortality rate in necrotizing
pancreatitis patients treated by continuous closed lav-
age, zipper technique, and open drainage was 19%,
24%, and 20.1%, respectively, and that the differences
between the groups were not signiﬁcant. The closed
lavage group had a lower incidence of ﬁstula formation
(pancreatic ﬁstula and intestinal ﬁstula) and postopera-
tive hemorrhage, but a higher rate of repeat operation,
whereas the zipper technique and open drainage were
characterized by a higher incidence of ﬁstula formation
and postoperative hemorrhage, but a lower rate of
repeat operation.
It is difﬁcult to conclude from currently available evi-
dence whether continuous closed lavage or open drain-
age (or the zipper technique) is better, and in recent
years one of these drainage techniques has been chosen
freely by surgeons according to the extent of infected
necrotic tissue. Continuous closed lavage is chosen
when necrotic tissue is localized around the pancreas,
and open drainage is recommended if the necrotic area
has spread from the root of the mesocolon to the right
and/or left paracolic gutter.48
Recently, less-invasive procedures have been pre-
ferred. Because the pancreas is a retroperitoneal organ,
necrosectomy alone by a retroperitoneal approach is
performed with simultaneous local lavage (Level 2c).49,50
The beneﬁts of this procedure are: (1) peritonitis can be
prevented because the abdominal cavity is not entered
and infecting organisms are not disseminated into the
peritoneal cavity, (2) oral intake can be resumed shortly
after the operation, (3) the risk of intestinal ﬁstula for-
mation is low, and (4) the incidence of wound infection
and abdominal wall incisional hernia is minimized. The
disadvantages are associated with the approach being
near the head of the pancreas. It is difﬁcult to reach the
posterior surface of the duodenum by a retroperitoneal
approach from the right side, and an aggressive proce-
dure involves the risk of massive bleeding as a result of
damage to the duodenal wall and portal veins.
Moreover, new less-invasive procedures such as per-
cutaneous necrosectomy (Level 2c)51–53 and endoscopic
transgastric necrosectomy54 have been tried and yielded
favorable results. Proper evaluation of these new man-
agement procedures will require the collection of data
from additional cases and follow-up examinations.
Pancreatic abscess
CQ7. How should pancreatic abscess be managed?
CQ8. What is the indication for surgical drainage in
pancreatic abscess?
Surgical or percutaneous drainage should be per-
formed for pancreatic abscess (Recommendation B). If
the clinical ﬁndings of pancreatic abscess are not im-
proved by percutaneous drainage, surgical drainage
should be performed immediately (Recommendation
A)
Pancreatic abscess is an indication for surgical interven-
tion, just as for infected pancreatic necrosis. Pus collec-
tion is the main lesion in most pancreatic abscess
patients, and it has been recently reported (Level 3b)55,56
that 78%–86% of patients can be managed by percuta-
neous drainage alone. If a safe puncture route is assured
by imaging guidance, this procedure may be the ﬁrst
choice as an aggressive treatment for pancreatic ab-
scess. However, it should be noted that the favorable
results reported for this treatment have all been based
on retrospective studies, and some of the cases were not
pancreatic abscess cases. For example, when severe
cases with a Ranson score of 5 or more (Level 2b)57 and
cases having multiple abscesses (Level 4)58  were in-
cluded in the study, the one-stage healing rates of percu-
taneous drainage declined to 30%–47%. When no
improvement in clinical ﬁndings is observed after percu-
taneous drainage, surgical drainage should be per-
formed immediately instead of monitoring the clinical
course.59
Pancreatic pseudocysts
CQ9. What are the indications for drainage treat-
ment in pancreatic pseudocysts?
Pancreatic pseudocysts that give rise to symptoms and
complications or the diameter of which increases
should be treated by drainage (Recommendation A)
Generally agreed indications for drainage treatment of
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symptoms, such as abdominal pain; (2) complication by
infection or bleeding; (3) increase in size during the
observation period; (4) a diameter of 6cm or more; and
(5) no tendency to decrease in size during at least 6
weeks of observation. There are no reports opposing
indications (1) to (3), but because pseudocysts of 6cm
or larger in diameter may spontaneously resolve after a
long follow-up period of 6 weeks or more, (4) and (5),
known as “6cm–6 week criteria,” are not absolute indi-
cations for drainage (Levels 3b–4).60,61
CQ10. What is the indication for surgical interven-
tion in pancreatic pseudocysts?
Pancreatic pseudocysts that do not tend to improve in
response to percutaneous drainage or endoscopic
drainage should be managed surgically (Recommen-
dation A)
The drainage procedures for pancreatic pseudocysts in-
clude percutaneous, endoscopic, and surgical drainage
(mainly cystoenteric anastomosis). Percutaneous drain-
age, which is the least invasive and has a cure rate of
80%–100%, is considered a promising alternative to
surgical drainage (Levels 2c–3c).62,63 However, some re-
ports have suggested that in a few cases pseudocysts only
temporarily resolve after percutaneous drainage (Level
3b),64 whereas other reports have indicated that the com-
plete cure rate as a result of surgical drainage is better
than that using other drainage procedures (Level 3b).65,66
One prospective controlled study (Level 2b)57 yielded a
one-stage cure rate using percutaneous drainage and
surgical drainage of 77% (20/26) and 73% (18/26), re-
spectively, with no signiﬁcant differences between them.
Because it has been reported that the average dura-
tion of catheterization for percutaneous drainage is 16–
42 days in cases that respond (Levels 2c–3b),62,63 surgical
drainage, such as cystoenteric anastomosis, should be
performed if there is no tendency toward improvement
even after this duration. When deciding whether the
disease is an indication for percutaneous drainage, it is
critical to identify the morphology of the pancreatic
duct and its relationship to the pancreatic cyst. Percuta-
neous drainage has been found to be effective in cases in
which the pancreatic duct has normal morphology and
in which the pancreatic duct is stenosed but does not
communicate with the cyst.67 There is a report68 that
percutaneous drainage is often ineffective for pancre-
atic pseudocysts complicated by splenic parenchymal
involvement, but that distal pancreatectomy and sple-
nectomy are effective.
Endoscopic management may be indicated in some
cases of pancreatic pseudocyst. Transintestinal drain-
age, such as by transgastric and transduodenal drainage
(Level 4), and transpapillary drainage (Level 4),69–71 are
indicated, but transgastric drainage should be per-
formed only when compression of the intestinal wall by
a cyst can be conﬁrmed endoscopically. It has been
suggested that guidance by endoscopic ultrasonography
may enhance the safety of drainage procedures (Level
4).72  Transpapillary drainage can be used in cases in
which there is communication between the cysts and
pancreatic ducts but a transintestinal approach cannot
be used. Major complications of endoscopic manage-
ment include bleeding, infection, and perforation, but
there have been no reliable reports comparing effec-
tiveness and safety with that of surgical management.
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